Fingerprint
Dive into the research topics of 'Phase I-II trial of imatinib mesylate (Gleevec; STI571) in treatment of recurrent oligodendroglioma and mixed oligoastrocytoma. North central cancer treatment group study N0272 (ALLIANCE/NCCTG)'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically